Related Experiment Video
Updated: Jul 26, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The dysregulation of lncRNAs by epigenetic factors in human pathologies
Yanli Zhang1, Xiaocong Wang2, Chen Zhang3
1Central Laboratory, The First Hospital of Jilin University, Changchun, Jilin, China; Key Laboratory of Organ Regeneration and Transplantation, Ministry of Education, Changchun, Jilin 130021, China; Department of Echocardiography, The First Hospital of Jilin University, Changchun, Jilin, China.
Abstract:
Dysregulation of long noncoding RNAs (lncRNAs) contributes to numerous human diseases, including cancers and autoimmune diseases (ADs). Given the importance of lncRNAs in disease initiation and progression, a deeper understanding of their complex regulatory network is required to facilitate their use as therapeutic targets for ADs. In this review, we summarize how lncRNAs are dysregulated in pathological states by epigenetic factors, including RNA-binding proteins, chemical modifications (N6-methyladenosine, 5-methylcytosine, 7-methylguanosine, adenosine-to-inosine editing, microRNA, alternative splicing, DNA methylation, and histone modification). Moreover, the roles of lncRNA epigenetic regulators in immune response and ADs are discussed, providing new insights into the complicated epigenetic factor-lncRNA network, thus, laying a theoretical foundation for future research and clinical application of lncRNAs.
Insights
Long noncoding RNAs (lncRNAs) are crucial in diseases like cancer and autoimmune diseases (ADs). This review explores how epigenetic factors dysregulate lncRNAs, offering insights for new AD therapies.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Long noncoding RNAs (lncRNAs) play significant roles in the initiation and progression of various human diseases.
- Dysregulation of lncRNAs is implicated in pathologies such as cancers and autoimmune diseases (ADs).
- Understanding the complex regulatory networks of lncRNAs is essential for developing novel therapeutic strategies for ADs.
Purpose of the Study:
- To review the mechanisms by which epigenetic factors dysregulate lncRNAs in pathological conditions.
- To discuss the involvement of lncRNA epigenetic regulators in immune responses and autoimmune diseases.
- To provide a theoretical foundation for the clinical application of lncRNAs in ADs.
Main Methods:
- Literature review summarizing epigenetic regulation of lncRNAs.
- Analysis of lncRNA dysregulation by epigenetic factors including RNA-binding proteins and chemical modifications.
- Discussion of the roles of lncRNA epigenetic regulators in immune response and ADs.
Main Results:
- Epigenetic factors such as RNA-binding proteins, chemical modifications (e.g., N6-methyladenosine, DNA methylation, histone modification), microRNA, and alternative splicing contribute to lncRNA dysregulation.
- lncRNA epigenetic regulators are involved in immune responses and the pathogenesis of autoimmune diseases.
- A complex interplay exists between epigenetic factors and lncRNAs in disease development.
Conclusions:
- Epigenetic dysregulation of lncRNAs is a key factor in the pathogenesis of autoimmune diseases.
- Targeting the epigenetic regulation of lncRNAs presents a promising avenue for developing new therapies for ADs.
- Further research into the epigenetic factor-lncRNA network will advance the clinical application of lncRNAs for treating ADs.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
X-chromosome...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Neural Regulation
Spreading of Chromatin Modifications
Writers
The writer...

